Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints - Administrative Supplement

项目概要 在该项目中，“饮酒水平（酗酒、饮酒量）和酒精后果：使用国家数据来识别 临床试验终点”（R01AA025309），流行病学数据已被用来调查以下关系： 酗酒指标表明酒精依赖和其他饮酒后果的风险。大部分工作 这项研究的重点是非戒酒减少是否会改善个人的感觉和功能 跨越广泛的领域。在该项目中，饮酒减少量主要通过世界各地来衡量 卫生组织 (WHO) 风险饮酒水平：极高风险、高风险、中度风险和低风险。这些 代表特定性别每天消耗的平均乙醇量。健康成果涵盖了 广泛的领域，包括酒精依赖（发生、持续）、功能受损、肝脏 疾病、AUDIT-C 筛查评分、药物使用障碍、抑郁/焦虑障碍和心血管疾病 疾病。该项目还撰写了一些论文，讨论有关世界卫生组织风险饮酒水平的类似问题 来自随机临床试验的治疗数据。然而，该研究并未包括世界卫生组织风险之间的关系 饮酒水平涉及其他重要变量，这些变量通常与饮酒水平高度相关，也与 结果已经分析过了。特别是，这些额外的变量包括对酒精的耐受性；家族史 酒精使用障碍；和性少数地位。此外，没有关于是否经历过的信息 作为性少数群体成员的歧视会缓和性少数地位与性少数群体的关系 世界卫生组织风险饮酒水平。因此，本行政补充文件的目标 1 是进行这些额外的 对世界卫生组织风险饮酒水平和酒精耐受性、酒精使用障碍家族史以及性行为的分析 少数地位，这将带来意想不到的成本。此外，没有任何文件总结现有的 有关重度饮酒和酒精使用障碍 (AUD) 流行病学的信息，包括调查结果 项目，以医疗保健提供者用户友好的形式。医疗保健提供者往往不了解 大量饮酒和澳元的流行病学以及非戒酒减少饮酒的好处。提供这个 他们的知识可以帮助他们改进筛查并对患者进行简短的干预。因此， 本行政补充文件的目标 2 是为医疗保健提供者准备一份文件，其中总结了 准确了解酗酒和酒精使用障碍的流行病学，以便 易于医疗保健提供者理解和使用。这项工作还将涉及意想不到的费用。

PROJECT SUMMARY In the project, “Drinking Levels (Binge, Volume) And Alcohol Consequences: Using National Data To Identify Clinical Trial Endpoints” (R01AA025309), epidemiologic data have been used to investigate the relationship of heavy drinking indicators to the risk for alcohol dependence and other drinking consequences. Much of the work for this study has focused on whether non-abstinent drinking reductions improve how individuals feel and function across a broad range of domains. In the project, drinking reduction has primarily been measured by the World Health Organization (WHO) risk drinking levels: very high risk, high risk, moderate risk, and low risk. These represent gender-specific average volumes of ethanol consumed per day. Health outcomes have covered a broad range of domains, including alcohol dependence (occurrence, persistence), impaired functioning, liver disease, AUDIT-C screening scores, drug use disorders, depressive/anxiety disorders, and cardiovascular disease. The project has also contributed to papers addressing similar issues regarding WHO risk drinking levels in treatment data from randomized clinical trials. However, the study did not include the relationship of WHO risk drinking levels to additional important variables that are often highly related to drinking levels and also to the outcomes already analyzed. In particular, these additional variables include tolerance to alcohol; family history of alcohol use disorders; and sexual minority status. In addition, no information exists on whether experiencing discrimination as a member of a sexual minority group moderates the relationship of sexual minority status to WHO risk drinking levels. Therefore, Aim 1 of this administrative supplement is to conduct these additional analyses on WHO risk drinking levels and alcohol tolerance, family history of alcohol use disorders, and sexual minority status, which will involve unanticipated costs. Furthermore, no document exists that summarizes extant information on the epidemiology of heavy drinking and alcohol use disorders (AUD), including the findings of the project, in a user-friendly form for healthcare providers. Healthcare providers are often not knowledgeable about the epidemiology of heavy drinking and AUD and the benefits of non-abstinent drinking reduction. Providing this knowledge to them may help them do improved screening and brief interventions with their patients. Therefore, Aim 2 of this administrative supplement is to prepare a document for healthcare providers that summarizes accurate knowledge about the epidemiology of heavy drinking and alcohol use disorders in a manner that will be easy for the healthcare providers to understand and use. This work will also involve unanticipated costs.